Schedule 13G ownership disclosure
Agios Pharmaceuticals Inc
Security class unavailable · CUSIP: 00847X104
Event date: 2023-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,200,757
- Percent of class
- 3.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-23-000049
- Form type
- SC 13G
- Filer
- AGIOS PHARMACEUTICALS, INC.
- CIK
- CIK 1439222
- Filed
- Nov 09, 2023
- Reporting period
- Oct 31, 2023
- Description
- Schedule 13G beneficial ownership